# VH4524184 Third-Generation INSTI Phase 1

**ID:** TRT-008
**Year:** 2024
**Source:** CID
**Link:** [https://academic.oup.com/cid/article/81/3/510/8090171](https://academic.oup.com/cid/article/81/3/510/8090171)

---

## Abstract

Phase 1 evaluation of third-generation integrase inhibitor with enhanced resistance profile and long-acting potential.

---

## Key Concepts

- Primary research focus from 2023-2025 HIV literature
- Relevant to understanding HIV biology, treatment, or prevention
- Contributes to the broader HIV research landscape

---

## Relevance to Project

This paper contributes to the Ternary VAE bioinformatics project by providing context on:
- HIV sequence evolution and variability
- Biological constraints on viral fitness
- Therapeutic targets and resistance mechanisms

---

*Added: 2025-12-24*
